Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,495	265 Pages	MarketLine	August, 2022	MTLN17403552

Best Price Guarantee
Price	from $1,495
Length	265 Pages
Publisher	MarketLine
Published Date	August, 2022
SKU	MTLN17403552

Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
The market value is evaluated at ex-factory prices.
Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
Note that any volumes of 1 (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2021 annual average exchange rates.
The global generics market had total revenues of $321.4 billion in 2021, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2021.
Market consumption volume increased with a CAGR of 1.9% between 2016 and 2021, to reach a total of 47.0 % in 2021.
Over the past five years, the global generics market recorded growth of 5.2%. Growth has primarily been driven by demographic trends.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the global generics market by value in 2021?
What will be the size of the global generics market in 2026?
What factors are affecting the strength of competition in the global generics market?
How has the market performed over the last five years?
How large is the global generics market in relation to its regional counterparts?

1 EXECUTIVE SUMMARY: 1.1. Market value; 1.2. Market value forecast; 1.3. Market volume; 1.4. Market volume forecast; 1.5. Geography segmentation; 1.6. Competitive Landscape
2 Introduction: 2.1. What is this report about?; 2.2. Who is the target reader?; 2.3. How to use this report; 2.4. Definitions
3 Global Generics: 3.1. Market Overview; 3.2. Market Data; 3.3. Market Segmentation; 3.4. Market outlook; 3.5. Five forces analysis
4 Macroeconomic Indicators: 4.1. Country data
5 Generics in Asia-Pacific: 5.1. Market Overview; 5.2. Market Data; 5.3. Market Segmentation; 5.4. Market outlook; 5.5. Five forces analysis
6 Generics in Europe: 6.1. Market Overview; 6.2. Market Data; 6.3. Market Segmentation; 6.4. Market outlook; 6.5. Five forces analysis
7 Macroeconomic Indicators: 7.1. Country data
8 Generics in France: 8.1. Market Overview; 8.2. Market Data; 8.3. Market Segmentation; 8.4. Market outlook; 8.5. Five forces analysis
9 Macroeconomic Indicators: 9.1. Country data
10 Generics in Germany: 10.1. Market Overview; 10.2. Market Data; 10.3. Market Segmentation; 10.4. Market outlook; 10.5. Five forces analysis
11 Macroeconomic Indicators: 11.1. Country data
12 Generics in Italy: 12.1. Market Overview; 12.2. Market Data; 12.3. Market Segmentation; 12.4. Market outlook; 12.5. Five forces analysis
13 Macroeconomic Indicators: 13.1. Country data
14 Generics in Japan: 14.1. Market Overview; 14.2. Market Data; 14.3. Market Segmentation; 14.4. Market outlook; 14.5. Five forces analysis
15 Macroeconomic Indicators: 15.1. Country data
16 Generics in Australia: 16.1. Market Overview; 16.2. Market Data; 16.3. Market Segmentation; 16.4. Market outlook; 16.5. Five forces analysis
17 Macroeconomic Indicators: 17.1. Country data
18 Generics in Canada: 18.1. Market Overview; 18.2. Market Data; 18.3. Market Segmentation; 18.4. Market outlook; 18.5. Five forces analysis
19 Macroeconomic Indicators: 19.1. Country data
20 Generics in China: 20.1. Market Overview; 20.2. Market Data; 20.3. Market Segmentation; 20.4. Market outlook; 20.5. Five forces analysis
21 Macroeconomic Indicators: 21.1. Country data
22 Generics in The Netherlands: 22.1. Market Overview; 22.2. Market Data; 22.3. Market Segmentation; 22.4. Market outlook; 22.5. Five forces analysis
23 Macroeconomic Indicators: 23.1. Country data
24 Generics in Spain: 24.1. Market Overview; 24.2. Market Data; 24.3. Market Segmentation; 24.4. Market outlook; 24.5. Five forces analysis
25 Macroeconomic Indicators: 25.1. Country data
26 Generics in The United Kingdom: 26.1. Market Overview; 26.2. Market Data; 26.3. Market Segmentation; 26.4. Market outlook; 26.5. Five forces analysis
27 Macroeconomic Indicators: 27.1. Country data
28 Generics in The United States: 28.1. Market Overview; 28.2. Market Data; 28.3. Market Segmentation; 28.4. Market outlook; 28.5. Five forces analysis
29 Macroeconomic Indicators: 29.1. Country data
30 Company Profiles
31 Appendix: 31.1. Methodology; 31.2. About MarketLine
List of Tables: Table 1: Global generics market value: $ billion, 2016-21; Table 2: Global generics market volume: %, 2016-21; Table 3: Global generics market geography segmentation: $ billion, 2021; Table 4: Global generics market value forecast: $ billion, 2021-26; Table 5: Global generics market volume forecast: %, 2021-26; Table 6: Global size of population (million), 2017-21; Table 7: Global gdp (constant 2005 prices, $ billion), 2017-21; Table 8: Global gdp (current prices, $ billion), 2017-21; Table 9: Global inflation, 2017-21; Table 10: Global consumer price index (absolute), 2017-21; Table 11: Global exchange rate, 2017-21; Table 12: Asia-Pacific generics market value: $ billion, 2016-21; Table 13: Asia-Pacific generics market volume: %, 2016-21; Table 14: Asia-Pacific generics market geography segmentation: $ billion, 2021; Table 15: Asia-Pacific generics market value forecast: $ billion, 2021-26; Table 16: Asia-Pacific generics market volume forecast: %, 2021-26; Table 17: Europe generics market value: $ billion, 2016-21; Table 18: Europe generics market volume: %, 2016-21; Table 19: Europe generics market geography segmentation: $ billion, 2021; Table 20: Europe generics market value forecast: $ billion, 2021-26; Table 21: Europe generics market volume forecast: %, 2021-26; Table 22: Europe size of population (million), 2017-21; Table 23: Europe gdp (constant 2005 prices, $ billion), 2017-21; Table 24: Europe gdp (current prices, $ billion), 2017-21; Table 25: Europe inflation, 2017-21; Table 26: Europe consumer price index (absolute), 2017-21; Table 27: Europe exchange rate, 2017-21; Table 28: France generics market value: $ million, 2016-21; Table 29: France generics market volume: %, 2016-21; Table 30: France generics market geography segmentation: $ million, 2021; Table 31: France generics market value forecast: $ million, 2021-26; Table 32: France generics market volume forecast: %, 2021-26; Table 33: France size of population (million), 2017-21; Table 34: France gdp (constant 2005 prices, $ billion), 2017-21; Table 35: France gdp (current prices, $ billion), 2017-21; Table 36: France inflation, 2017-21; Table 37: France consumer price index (absolute), 2017-21; Table 38: France exchange rate, 2017-21; Table 39: Germany generics market value: $ billion, 2016-21; Table 40: Germany generics market volume: %, 2016-21; Table 41: Germany generics market geography segmentation: $ billion, 2021; Table 42: Germany generics market value forecast: $ billion, 2021-26; Table 43: Germany generics market volume forecast: %, 2021-26; Table 44: Germany size of population (million), 2017-21; Table 45: Germany gdp (constant 2005 prices, $ billion), 2017-21; Table 46: Germany gdp (current prices, $ billion), 2017-21; Table 47: Germany inflation, 2017-21; Table 48: Germany consumer price index (absolute), 2017-21; Table 49: Germany exchange rate, 2017-21; Table 50: Italy generics market value: $ million, 2016-21; Table 51: Italy generics market volume: %, 2016-21; Table 52: Italy generics market geography segmentation: $ million, 2021; Table 53: Italy generics market value forecast: $ million, 2021-26; Table 54: Italy generics market volume forecast: %, 2021-26; Table 55: Italy size of population (million), 2017-21; Table 56: Italy gdp (constant 2005 prices, $ billion), 2017-21; Table 57: Italy gdp (current prices, $ billion), 2017-21; Table 58: Italy inflation, 2017-21; Table 59: Italy consumer price index (absolute), 2017-21; Table 60: Italy exchange rate, 2017-21; Table 61: Japan generics market value: $ billion, 2016-21; Table 62: Japan generics market volume: %, 2016-21; Table 63: Japan generics market geography segmentation: $ billion, 2021; Table 64: Japan generics market value forecast: $ billion, 2021-26; Table 65: Japan generics market volume forecast: %, 2021-26; Table 66: Japan size of population (million), 2017-21; Table 67: Japan gdp (constant 2005 prices, $ billion), 2017-21; Table 68: Japan gdp (current prices, $ billion), 2017-21; Table 69: Japan inflation, 2017-21; Table 70: Japan consumer price index (absolute), 2017-21; Table 71: Japan exchange rate, 2017-21; Table 72: Australia generics market value: $ million, 2016-21; Table 73: Australia generics market volume: %, 2016-21; Table 74: Australia generics market geography segmentation: $ million, 2021; Table 75: Australia generics market value forecast: $ million, 2021-26; Table 76: Australia generics market volume forecast: %, 2021-26; Table 77: Australia size of population (million), 2017-21; Table 78: Australia gdp (constant 2005 prices, $ billion), 2017-21; Table 79: Australia gdp (current prices, $ billion), 2017-21; Table 80: Australia inflation, 2017-21
List of Figures: Figure 1: Global generics market value: $ billion, 2016-21; Figure 2: Global generics market volume: %, 2016-21; Figure 3: Global generics market geography segmentation: % share, by value, 2021; Figure 4: Global generics market value forecast: $ billion, 2021-26; Figure 5: Global generics market volume forecast: %, 2021-26; Figure 6: Forces driving competition in the global generics market, 2021; Figure 7: Drivers of buyer power in the global generics market, 2021; Figure 8: Drivers of supplier power in the global generics market, 2021; Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2021; Figure 10: Factors influencing the threat of substitutes in the global generics market, 2021; Figure 11: Drivers of degree of rivalry in the global generics market, 2021; Figure 12: Asia-Pacific generics market value: $ billion, 2016-21; Figure 13: Asia-Pacific generics market volume: %, 2016-21; Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2021; Figure 15: Asia-Pacific generics market value forecast: $ billion, 2021-26; Figure 16: Asia-Pacific generics market volume forecast: %, 2021-26; Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2021; Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2021; Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2021; Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2021; Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2021; Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2021; Figure 23: Europe generics market value: $ billion, 2016-21; Figure 24: Europe generics market volume: %, 2016-21; Figure 25: Europe generics market geography segmentation: % share, by value, 2021; Figure 26: Europe generics market value forecast: $ billion, 2021-26; Figure 27: Europe generics market volume forecast: %, 2021-26; Figure 28: Forces driving competition in the generics market in Europe, 2021; Figure 29: Drivers of buyer power in the generics market in Europe, 2021; Figure 30: Drivers of supplier power in the generics market in Europe, 2021; Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2021; Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2021; Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2021; Figure 34: France generics market value: $ million, 2016-21; Figure 35: France generics market volume: %, 2016-21; Figure 36: France generics market geography segmentation: % share, by value, 2021; Figure 37: France generics market value forecast: $ million, 2021-26; Figure 38: France generics market volume forecast: %, 2021-26; Figure 39: Forces driving competition in the generics market in France, 2021; Figure 40: Drivers of buyer power in the generics market in France, 2021; Figure 41: Drivers of supplier power in the generics market in France, 2021; Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2021; Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2021; Figure 44: Drivers of degree of rivalry in the generics market in France, 2021; Figure 45: Germany generics market value: $ billion, 2016-21; Figure 46: Germany generics market volume: %, 2016-21; Figure 47: Germany generics market geography segmentation: % share, by value, 2021; Figure 48: Germany generics market value forecast: $ billion, 2021-26; Figure 49: Germany generics market volume forecast: %, 2021-26; Figure 50: Forces driving competition in the generics market in Germany, 2021; Figure 51: Drivers of buyer power in the generics market in Germany, 2021; Figure 52: Drivers of supplier power in the generics market in Germany, 2021; Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2021; Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2021; Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2021; Figure 56: Italy generics market value: $ million, 2016-21; Figure 57: Italy generics market volume: %, 2016-21; Figure 58: Italy generics market geography segmentation: % share, by value, 2021; Figure 59: Italy generics market value forecast: $ million, 2021-26; Figure 60: Italy generics market volume forecast: %, 2021-26; Figure 61: Forces driving competition in the generics market in Italy, 2021; Figure 62: Drivers of buyer power in the generics market in Italy, 2021; Figure 63: Drivers of supplier power in the generics market in Italy, 2021; Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2021; Figure 65: Factors influencing the threat of substitutes in the generics market in Italy, 2021; Figure 66: Drivers of degree of rivalry in the generics market in Italy, 2021; Figure 67: Japan generics market value: $ billion, 2016-21; Figure 68: Japan generics market volume: %, 2016-21; Figure 69: Japan generics market geography segmentation: % share, by value, 2021; Figure 70: Japan generics market value forecast: $ billion, 2021-26; Figure 71: Japan generics market volume forecast: %, 2021-26; Figure 72: Forces driving competition in the generics market in Japan, 2021; Figure 73: Drivers of buyer power in the generics market in Japan, 2021; Figure 74: Drivers of supplier power in the generics market in Japan, 2021; Figure 75: Factors influencing the likelihood of new entrants in the generics market in Japan, 2021; Figure 76: Factors influencing the threat of substitutes in the generics market in Japan, 2021; Figure 77: Drivers of degree of rivalry in the generics market in Japan, 2021; Figure 78: Australia generics market value: $ million, 2016-21; Figure 79: Australia generics market volume: %, 2016-21; Figure 80: Australia generics market geography segmentation: % share, by value, 2021